Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Abrams

Circulation

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Circulation|December 1, 1986
Tolerance to organic nitratesJ Abrams
Circulation|April 9, 2014
Long QT syndromeDominic J Abrams, Calum A Macrae
Circulation|June 4, 2019
Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia by Inhibition of Ca<sup>2+</sup>/Calmodulin-Dependent Kinase IIVassilios J Bezzerides, Ana Caballero, Suya Wang, et al.
Circulation|March 21, 2007
Comparison of noncontact and electroanatomic mapping to identify scar and arrhythmia late after the Fontan procedureDominic J Abrams, Mark J Earley, Simon C Sporton, et al.
Circulation|January 5, 2000
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group IIIP Greenland, J Abrams, G P Aurigemma, et al.
Circulation|July 18, 2019
Insights Into the Pathogenesis of Catecholaminergic Polymorphic Ventricular Tachycardia From Engineered Human Heart TissueSung-Jin Park, Donghui Zhang, Yan Qi, et al.
Circulation|January 27, 2016
Response to Letters Regarding Article, "Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation"Gaetano M De Ferrari, Veronica Dusi, Carla Spazzolini, et al.
Circulation|March 9, 2026
Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic CardiomyopathyChristoffer R Vissing, Anna Axelsson Raja, Adam S Helms, et al.
Circulation|May 29, 2015
Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic DenervationGaetano M De Ferrari, Veronica Dusi, Carla Spazzolini, et al.
Circulation|May 25, 2023
Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe RegistrySarah Abou Alaiwi, Thomas M Roston, Peter Marstrand, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Circulation|December 1, 1986
Tolerance to organic nitratesJ Abrams
Circulation|April 9, 2014
Long QT syndromeDominic J Abrams, Calum A Macrae
Circulation|June 4, 2019
Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia by Inhibition of Ca<sup>2+</sup>/Calmodulin-Dependent Kinase IIVassilios J Bezzerides, Ana Caballero, Suya Wang, et al.
Circulation|March 21, 2007
Comparison of noncontact and electroanatomic mapping to identify scar and arrhythmia late after the Fontan procedureDominic J Abrams, Mark J Earley, Simon C Sporton, et al.
Circulation|January 5, 2000
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group IIIP Greenland, J Abrams, G P Aurigemma, et al.
Circulation|July 18, 2019
Insights Into the Pathogenesis of Catecholaminergic Polymorphic Ventricular Tachycardia From Engineered Human Heart TissueSung-Jin Park, Donghui Zhang, Yan Qi, et al.
Circulation|January 27, 2016
Response to Letters Regarding Article, "Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation"Gaetano M De Ferrari, Veronica Dusi, Carla Spazzolini, et al.
Circulation|March 9, 2026
Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic CardiomyopathyChristoffer R Vissing, Anna Axelsson Raja, Adam S Helms, et al.
Circulation|May 29, 2015
Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic DenervationGaetano M De Ferrari, Veronica Dusi, Carla Spazzolini, et al.
Circulation|May 25, 2023
Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe RegistrySarah Abou Alaiwi, Thomas M Roston, Peter Marstrand, et al.
Pageof 2